Vyas S P, Gogoi P J, Pande S, Dixit V K
Pharmaceutics Laboratory, Department of Pharmaceutical Sciences, Sagar, India.
J Microencapsul. 1991 Oct-Dec;8(4):447-54. doi: 10.3109/02652049109021868.
Enteric diastase spherules were prepared using cellulose acetate phthalate and eudragit RS-100 by emulsion solvent removal method. Factors that could affect the size shape and diastatic activity were studied. The studied factors include pH of aqueous media, temperature of dispersion media and concentration of surface active agent. Prepared enteric diastase spherules were investigated for stability and diastatic activity at different temperatures and pH in various buffer systems, in the presence and absence of pepsin, a gastric enzyme. Eudragit RS-100 based spherules were noted to be spherical and uniform in shape with an appreciable level of diastatic activity. However, diastase was observed to be released from such a system in a slow but controlled manner. Eudragit RS-100 was found to provide more stabilization to the diastase than the stabilization provided by cellulose acetate phthalate. The spherules when tested in in vitro and in situ were recorded to exhibit diastatic activity at 99 per cent potency level (based on an actually incorporated amount of diastase). The study reveals that enteric or pH sensitive diastase releasing systems hold promise and potential in the therapeutic application of digestive enzyme(s).
采用乳化溶剂去除法,使用邻苯二甲酸醋酸纤维素和尤特奇RS - 100制备肠溶淀粉酶微球。研究了可能影响其大小、形状和淀粉酶活性的因素。所研究的因素包括水相介质的pH值、分散介质的温度和表面活性剂的浓度。在有和没有胃酶胃蛋白酶的情况下,在不同温度和pH值的各种缓冲体系中,对制备的肠溶淀粉酶微球的稳定性和淀粉酶活性进行了研究。基于尤特奇RS - 100的微球呈球形且形状均匀,具有相当水平的淀粉酶活性。然而,观察到淀粉酶从这样的体系中缓慢但可控地释放。发现尤特奇RS - 100比邻苯二甲酸醋酸纤维素为淀粉酶提供了更多的稳定性。当在体外和体内进行测试时,微球在99%的效价水平(基于实际掺入的淀粉酶量)下表现出淀粉酶活性。该研究表明,肠溶或pH敏感的淀粉酶释放系统在消化酶的治疗应用中具有前景和潜力。